Terman et al. [14] postulated that the disrupted Man-6-P synthesis and hypersecretion of cathepsins by fibroblasts isolated from mucolipidosis II patients, resulting in low levels of these enzymes in lysosomes, could prevent apoptosis initiation upon the treatment with cytotoxic drugs. Here, CTSS is linked to mucolipidosis type II.